Opinion

Video

Dr. Fulla highlights an AI tool for patient follow-up for urologic conditions

“Our goal is to support patients throughout their entire journey with an intelligence chat system that not only evaluates them, but also answers many questions when their treating physician is not available, which is very common,” says Juan Fulla, MD, MSc.

In this interview, Juan Fulla, MD, MSc, discusses an artificial intelligence (AI)-based chat system that can assist in the follow-up of patients with urologic conditions. Fulla is the chief of the robotic program and an associate professor of urology at the University of Chile in Santiago, Chile.

Video Transcript:

I would like to mention an innovative project I'm working on. It's called UroAssist; it's a platform that will integrate various urological conditions. Currently, it focuses only on kidney stones and also BPH. Our goal is to support patients throughout their entire journey with an intelligence chat system that not only evaluates them, but also answers many questions when their treating physician is not available, which is very common. This is very relevant, for example, in the post-operative follow-up, where many patients are unable to retain all the information given at a discharge. And often, they have numerous questions that could be easily addressed. This, we think, allows physicians to save time and of course, focus on more critical tasks. UroAssist serves as a follow-up tool, basically, by asking patients questions through questionnaires to monitor their progress very objectively, but also providing physicians with clear evidence of the patient's evolution over the time.

This transcription has been edited for clarity.

Related Videos
Man talking with doctor | Image Credit: © RFBSIP - stock.adobe.com
Andrew C. Peterson, MD, MPH, answers a question during a Zoom interview
Man talking with a doctor | Image Credit: © Chinnapong - stock.adobe.com
DNA helix | Image Credit: © BillionPhotos.com - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.